Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-10-26 Purchase | 2023-10-30 9:51 pm | ASP Isotopes Inc. | ASPI | Moore Duncan Director | 104,167 | $0.96 | $100,000 | 854,167 (Direct) | View |
| 2023-06-29 Purchase | 2023-07-03 07:04 am | ASP Isotopes Inc. | ASPI | Moore Duncan Director | 100,000 | $0.4999 | $49,990 | 550,000 (Direct) | View |
| 2023-05-18 Purchase | 2023-05-19 4:05 pm | ASP Isotopes Inc. | ASPI | Moore Duncan Director | 20,000 | $0.3115 | $6,230 | 450,000 (Direct) | View |
| 2023-05-10 Purchase | 2023-05-16 08:09 am | ASP Isotopes Inc. | ASPI | Moore Duncan Director | 10,000 | $0.5 | $5,000 | 430,000 (Direct) | View |
| 2023-04-06 Purchase | 2023-04-11 10:50 am | ASP Isotopes Inc. | ASPI | Moore Duncan Director | 20,000 | $0.9999 | $19,998 | 420,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-08-10 Option Award | 2023-10-30 9:51 pm | N/A N/A | ASP Isotopes Inc. | ASPI | Moore Duncan Director | 200,000 | $0 | 854,167 (Direct) | View |
| 2022-11-15 Option Award | 2022-11-16 12:41 pm | N/A N/A | ASP Isotopes Inc. | ASPI | Moore Duncan Director | 200,000 | $0 | 400,000 (Direct) | View |
Ownership | 2022-11-14 4:40 pm | N/A N/A | ASP Isotopes Inc. | ASPI | Moore Duncan Director | 0 | $0 | 296,000 (Direct) | View |
Ownership | 2021-12-22 4:30 pm | N/A N/A | Allarity Therapeutics Inc. | ALLR | Moore Duncan Director | 0 | $0 | 64,666 (Direct) | View |